Pharmaceuticals
IVI, INOVIO, and KNIH to Partner with CEPI in Phase 1/2 Clinical Trial of INOVIO's COVID-19 DNA Vaccine in South Korea
PLYMOUTH MEETING, Pennsylvania and SEOUL, South Korea, April 16, 2020 /PRNewswire/ -- The International Vaccine Institute (IVI) announced today that the Coalition for Epidemic Preparedness Innovations (CEPI) has granted$6.9 million funding to INOVIO (NASDAQ:INO) to work with IVI and the Korea Nat...
2020-04-16 18:00
3209
Mayne Pharma Submits New Drug Application for E4/DRSP to the FDA
ADELAIDE, Australia and LIEGE, Belgium, April 16, 2020 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) and Mithra Pharmaceuticals, SA (Euronext Brussels: MITRA) today announced that Mayne Pharma has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA), seeking...
2020-04-16 12:30
5953
Three Chinese Vaccines against COVID-19 are on the Way
BEIJING, April 16, 2020 /PRNewswire/ -- According to the latest news from Science and Technology Daily (April 14th), two COVID-19 inactivated vaccines were just approved for a phase I & II combined clinical trial by the National Medical Products Administration (NMPA) ofChina, making them the firs...
2020-04-16 11:03
2326
Australia to test COVID-19 vaccine
MELBOURNE, Australia, April 15, 2020 /PRNewswire/ -- The first COVID-19 vaccine to be tested outside of theUSA, and only the third vaccine clinical trial in the world, will be conducted byAustralia's largest Phase 1 clinical trials specialist Nucleus Network. As part of the urgent global race to...
2020-04-15 11:15
1503
Lianhua Qingwen capsule (granule) was approved as an additional indication of COVID-19
SHIJIAZHUANG, China, April 15, 2020 /PRNewswire/ -- On April 14, 2020, Yiling Pharmaceutical announced that Yiling Pharmaceutical and its subsidiary Beijing Yiling Pharmaceutical had received the approval document of drug supplement application concerning the application for new indications of Li...
2020-04-15 05:55
7671
Antengene Announces Dosing of First Patient in the ATG-019 (KPT-9274) Phase 1 Trial, a First-in-Class Dual Inhibitor, for Advanced Solid Tumors and Non-Hodgkin's Lymphoma
SHANGHAI and PHILADELPHIA, April 14, 2020 /PRNewswire/ -- Antengene announced today that it has dosed the first patient inTaiwan, China in its phase 1 open-label clinical trial of ATG-019 (KPT-9274), a dual inhibitor of both PAK4 and NAMPT. This trial is being conducted to evaluate the safety and...
2020-04-14 21:15
1486
Shijiazhuang Yiling Pharmaceutical Co, Ltd. supports the battle against COVID-19 with "Lianhua Qingwen"
SHIJIAZHUANG, China, April 13, 2020 /PRNewswire/ -- Recently, Shijiazhuang Yiling Pharmaceutical Co, Ltd. announced that the ministry of foreign affairs of the People's Republic ofChina has purchased 700,000 boxes of Lianhua Qingwen and distribute them to eachChinese embassy. The health packages ...
2020-04-13 22:25
2642
Yiling Pharmaceutical Lianhua Qingwen capsules are widely used in China against the epidemic
SHIJIAZHUANG, China, April 13, 2020 /PRNewswire/ -- Wu Xiangjun, general manager of Yiling Pharmaceutical co., LTD., announced thatLianhua Qingwen capsules (granules) have been recommended by the National Health Commission and the State Administration of Traditional Medicine of China. The ministr...
2020-04-13 21:55
1990
Seegene Receives Health Canada Approval for its COVID-19 Assay
SEOUL, South Korea, April 13, 2020 /PRNewswire/ -- Seegene, Inc. announced that Health Canada (HC) authorized an interim order which allows the import and sale inCanada of Seegene's Allplex™ 2019-nCoV Assay, a Real-time RT-PCR test for SARS-CoV-2, the novel coronavirus responsible for the COVI...
2020-04-13 21:00
2300
PharmaBlock Opens New Chemistry and Engineering Technology Center in Zhejiang
NANJING, China, April 13, 2020 /PRNewswire/ -- Early this April, PharmaBlock Sciences (Nanjing), Inc. announced the launch of a new Chemistry and Engineering Technology Center (CETC) located next to its GMP manufacturing site in Shangyu,Zhejiang Province. Addition of the CETC will further strengt...
2020-04-13 20:00
1306
Antengene Corporation Appoints Former Celgene ANZ General Manager Thomas Karalis as Head of Asia Pacific Regions
SHANGHAI and MELBOURNE, Australia, April 13, 2020 /PRNewswire/ -- Antengene Corporation today announced the appointment of Mr. Thomas Karalis as Head of Asia Pacific Regions. In this position, Tom will be responsible for the commercialization of Antengene products inAustralia, New Zealand, S. Kor...
2020-04-13 20:00
3348
AGC to Expand Its Spanish Synthetic Pharmaceutical Production Base for Capacity Increase and Establishment of New R&D Facility
TOKYO, April 10, 2020 /PRNewswire/ -- AGC Inc. (AGC), a world-leading manufacturer of glass, chemicals and high-tech materials, has announced its decision to expand facilities at its synthetic pharmaceutical (*1) CDMO (*2) business subsidiary, AGC Pharma Chemicals Europe S. L. U., headquartered i...
2020-04-10 14:00
2247
Seneca Biopharma Announces Results of Meeting with FDA Regarding the Design of Phase 3 Trial for NSI-566 in ALS
GERMANTOWN, Maryland, April 9, 2020 /PRNewswire/ -- Seneca Biopharma, Inc. (Nasdaq: SNCA), a clinical-stage biopharmaceutical company focused on developing novel treatments for diseases of high unmet medical need, today announced that the company held a Type C meeting with the Office of Tissues a...
2020-04-09 20:00
3384
World-First Trial to Test Benefit of Intravenous Zinc in COVID-19 Fight
SYDNEY, April 9, 2020 /PRNewswire/ -- A world-first trial will see researchers from Austin Health and theUniversity of Melbourne use intravenous zinc to fight the symptoms of coronavirus (COVID-19). The trial will be led by Austin Health's Dr Joseph Ischia and Dr Oneel Patel from the Department ...
2020-04-09 15:57
1384
Bridge Biotherapeutics Discloses Interim Results from the First Cohort of Phase 2a Study of BBT-401, an Experimental Drug for Ulcerative Colitis
* The Interim data showed that 3 out of 9 evaluable patients on BBT-401 responded with more than 30% reduction in Total Mayo Score or 25% reduction in Partial Mayo Score * Safety and tolerability profiles remain consistent with results from Phase I trial in healthy volunteers SEONGNAM, South ...
2020-04-09 15:14
1403
EpiVax Partners with GAIA Vaccine Foundation to Make COVID-19 Vaccine License Free to Developing Countries
PROVIDENCE, Rhode Island, April 8, 2020 /PRNewswire/ -- EpiVax, Inc., is using advanced computational tools to accelerate a COVID-19 vaccine candidate (EPV-CoV19) for healthcare workers (HCW) into clinical trials in 6 months. Today, EpiVax announces its partnership with GAIA Vaccine Foundation ("...
2020-04-08 03:57
2489
HOYA/PENTAX Medical Issues Statement Regarding U.S. Department of Justice Settlement
MONTVALE, New Jersey and TOKYO, April 7, 2020 /PRNewswire/ -- HOYA Corporation and a subsidiary through PENTAX Medical division, Pentax of America, Inc. (collectively, "PENTAX" or "the Company"), today finalized a Deferred Prosecution Agreement (DPA) with the U.S. Department of Justice (DOJ) on i...
2020-04-07 23:36
3528
Kazia's Paxalisib Shows Positive Overall Survival Signal in Phase II Glioblastoma Study
SYDNEY, April 7, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to share positive interim data from its ongoing phase II study of paxalisib (formerly GDC-0084) in glioblastoma, the most common and most agg...
2020-04-07 20:00
3860
CROMSOURCE Announces Launch of COVID-19 Clinical Trial
VERONA, Italy, 7 April, 2020 /PRNewswire/ -- CROMSOURCE, an international contract research organization (CRO) with its global headquarters inVerona, Italy, has announced that it has initiated its first COVID-19 trial on behalf of a European pharmaceutical company. This trial is expected to be pe...
2020-04-07 19:01
2634
INOVIO Initiates Phase 1 Clinical Trial Of Its COVID-19 Vaccine and Plans First Dose Today
- Up to 40 Healthy Volunteers To Participate at Two Trial Locations - Preclinical Animal Studies Show Promising Immune Responses - Rapid Advancement Possible Through a Global Coalition of Collaborators, Partners, and Funders PLYMOUTH MEETING, Pennsylvania, April 6, 2020 /PRNewswire/ -- INOVIO...
2020-04-06 20:30
3249
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
5902
